Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Outcomes in Women Undergoing Multimodality Treatment for Advanced Stage Endometrial Carcinoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* FIGO stage III uterine carcinoma~* candidates for combined modality treatment (surgery, chemotherapy with carbo/Taxol, and radiation therapy)~Exclusion Criteria:~* Patients who are not FIGO stage III~* patients with carcinosarcoma histology~* patients who are ineligible for combined modality treatment

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: t

Study Arms:
- Quality of life evaluation (Type: EXPERIMENTAL): This prospective arm will consist of evaluating quality of life outcomes in women in women with advanced endometrial cancer undergoing adjuvant concurrent chemotherapy with carbo/Taxol and radiation therapy. Assessments will occur following surgery (baseline), 3, 6, 12, and 24 months.

Based on this trial design, predict the completion outcome and termination type (if applicable).